questionsmedicales.fr
Mélanges complexes
Produits biologiques
Vaccins
Vaccins antiviraux
Vaccins antiviraux : Questions médicales fréquentes
Termes MeSH sélectionnés :
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Vaccins antiviraux : Questions médicales les plus fréquentes",
"headline": "Vaccins antiviraux : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Vaccins antiviraux : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-02-24",
"dateModified": "2025-02-18",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Vaccins antiviraux"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Vaccins",
"url": "https://questionsmedicales.fr/mesh/D014612",
"about": {
"@type": "MedicalCondition",
"name": "Vaccins",
"code": {
"@type": "MedicalCode",
"code": "D014612",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D20.215.894"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Vaccins anti-adénovirus",
"alternateName": "Adenovirus Vaccines",
"url": "https://questionsmedicales.fr/mesh/D062705",
"about": {
"@type": "MedicalCondition",
"name": "Vaccins anti-adénovirus",
"code": {
"@type": "MedicalCode",
"code": "D062705",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D20.215.894.899.024"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Vaccins contre le SIDA",
"alternateName": "AIDS Vaccines",
"url": "https://questionsmedicales.fr/mesh/D016915",
"about": {
"@type": "MedicalCondition",
"name": "Vaccins contre le SIDA",
"code": {
"@type": "MedicalCode",
"code": "D016915",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D20.215.894.899.050"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Vaccins contre la COVID-19",
"alternateName": "COVID-19 Vaccines",
"url": "https://questionsmedicales.fr/mesh/D000086663",
"about": {
"@type": "MedicalCondition",
"name": "Vaccins contre la COVID-19",
"code": {
"@type": "MedicalCode",
"code": "D000086663",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D20.215.894.899.085"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Vaccin ChAdOx1 nCoV-19",
"alternateName": "ChAdOx1 nCoV-19",
"url": "https://questionsmedicales.fr/mesh/D000090985",
"about": {
"@type": "MedicalCondition",
"name": "Vaccin ChAdOx1 nCoV-19",
"code": {
"@type": "MedicalCode",
"code": "D000090985",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D20.215.894.899.085.063"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Ad26COVS1",
"alternateName": "Ad26COVS1",
"url": "https://questionsmedicales.fr/mesh/D000090984",
"about": {
"@type": "MedicalCondition",
"name": "Ad26COVS1",
"code": {
"@type": "MedicalCode",
"code": "D000090984",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D20.215.894.899.085.125"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Vaccins contre le cytomégalovirus",
"alternateName": "Cytomegalovirus Vaccines",
"url": "https://questionsmedicales.fr/mesh/D022482",
"about": {
"@type": "MedicalCondition",
"name": "Vaccins contre le cytomégalovirus",
"code": {
"@type": "MedicalCode",
"code": "D022482",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D20.215.894.899.120"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Vaccins contre la dengue",
"alternateName": "Dengue Vaccines",
"url": "https://questionsmedicales.fr/mesh/D053059",
"about": {
"@type": "MedicalCondition",
"name": "Vaccins contre la dengue",
"code": {
"@type": "MedicalCode",
"code": "D053059",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D20.215.894.899.162"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Vaccins contre la maladie à virus Ebola",
"alternateName": "Ebola Vaccines",
"url": "https://questionsmedicales.fr/mesh/D046129",
"about": {
"@type": "MedicalCondition",
"name": "Vaccins contre la maladie à virus Ebola",
"code": {
"@type": "MedicalCode",
"code": "D046129",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D20.215.894.899.205"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Vaccins contre les herpèsvirus",
"alternateName": "Herpesvirus Vaccines",
"url": "https://questionsmedicales.fr/mesh/D022283",
"about": {
"@type": "MedicalCondition",
"name": "Vaccins contre les herpèsvirus",
"code": {
"@type": "MedicalCode",
"code": "D022283",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D20.215.894.899.290"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Vaccin contre la varicelle",
"alternateName": "Chickenpox Vaccine",
"url": "https://questionsmedicales.fr/mesh/D019433",
"about": {
"@type": "MedicalCondition",
"name": "Vaccin contre la varicelle",
"code": {
"@type": "MedicalCode",
"code": "D019433",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D20.215.894.899.290.130"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Vaccin contre le zona",
"alternateName": "Herpes Zoster Vaccine",
"url": "https://questionsmedicales.fr/mesh/D053061",
"about": {
"@type": "MedicalCondition",
"name": "Vaccin contre le zona",
"code": {
"@type": "MedicalCode",
"code": "D053061",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D20.215.894.899.290.130.400"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Vaccin contre le zona",
"alternateName": "Herpes Zoster Vaccine",
"url": "https://questionsmedicales.fr/mesh/D053061",
"about": {
"@type": "MedicalCondition",
"name": "Vaccin contre le zona",
"code": {
"@type": "MedicalCode",
"code": "D053061",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D20.215.894.899.290.130.400"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Vaccins contre les virus herpès simplex",
"alternateName": "Herpes Simplex Virus Vaccines",
"url": "https://questionsmedicales.fr/mesh/D022301",
"about": {
"@type": "MedicalCondition",
"name": "Vaccins contre les virus herpès simplex",
"code": {
"@type": "MedicalCode",
"code": "D022301",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D20.215.894.899.290.400"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Vaccins contre la maladie de Marek",
"alternateName": "Marek Disease Vaccines",
"url": "https://questionsmedicales.fr/mesh/D022501",
"about": {
"@type": "MedicalCondition",
"name": "Vaccins contre la maladie de Marek",
"code": {
"@type": "MedicalCode",
"code": "D022501",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D20.215.894.899.290.500"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Vaccins antigrippaux",
"alternateName": "Influenza Vaccines",
"url": "https://questionsmedicales.fr/mesh/D007252",
"about": {
"@type": "MedicalCondition",
"name": "Vaccins antigrippaux",
"code": {
"@type": "MedicalCode",
"code": "D007252",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D20.215.894.899.302"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Vaccins contre l'encéphalite japonaise",
"alternateName": "Japanese Encephalitis Vaccines",
"url": "https://questionsmedicales.fr/mesh/D022321",
"about": {
"@type": "MedicalCondition",
"name": "Vaccins contre l'encéphalite japonaise",
"code": {
"@type": "MedicalCode",
"code": "D022321",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D20.215.894.899.320"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Vaccin contre la rougeole",
"alternateName": "Measles Vaccine",
"url": "https://questionsmedicales.fr/mesh/D008458",
"about": {
"@type": "MedicalCondition",
"name": "Vaccin contre la rougeole",
"code": {
"@type": "MedicalCode",
"code": "D008458",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D20.215.894.899.404"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Vaccin antiourlien",
"alternateName": "Mumps Vaccine",
"url": "https://questionsmedicales.fr/mesh/D009108",
"about": {
"@type": "MedicalCondition",
"name": "Vaccin antiourlien",
"code": {
"@type": "MedicalCode",
"code": "D009108",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D20.215.894.899.488"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Vaccins contre les papillomavirus",
"alternateName": "Papillomavirus Vaccines",
"url": "https://questionsmedicales.fr/mesh/D053918",
"about": {
"@type": "MedicalCondition",
"name": "Vaccins contre les papillomavirus",
"code": {
"@type": "MedicalCode",
"code": "D053918",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D20.215.894.899.498"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Vaccin recombinant quadrivalent contre les papillomavirus humains de type 6, 11, 16 et 18",
"alternateName": "Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18",
"url": "https://questionsmedicales.fr/mesh/D000068857",
"about": {
"@type": "MedicalCondition",
"name": "Vaccin recombinant quadrivalent contre les papillomavirus humains de type 6, 11, 16 et 18",
"code": {
"@type": "MedicalCode",
"code": "D000068857",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D20.215.894.899.498.500"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Vaccins contre les virus para-influenza",
"alternateName": "Parainfluenza Vaccines",
"url": "https://questionsmedicales.fr/mesh/D022241",
"about": {
"@type": "MedicalCondition",
"name": "Vaccins contre les virus para-influenza",
"code": {
"@type": "MedicalCode",
"code": "D022241",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D20.215.894.899.500"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Vaccins antipoliomyélitiques",
"alternateName": "Poliovirus Vaccines",
"url": "https://questionsmedicales.fr/mesh/D023321",
"about": {
"@type": "MedicalCondition",
"name": "Vaccins antipoliomyélitiques",
"code": {
"@type": "MedicalCode",
"code": "D023321",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D20.215.894.899.623"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Vaccin antipoliomyélitique inactivé",
"alternateName": "Poliovirus Vaccine, Inactivated",
"url": "https://questionsmedicales.fr/mesh/D011054",
"about": {
"@type": "MedicalCondition",
"name": "Vaccin antipoliomyélitique inactivé",
"code": {
"@type": "MedicalCode",
"code": "D011054",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D20.215.894.899.623.500"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Vaccin antipoliomyélitique oral",
"alternateName": "Poliovirus Vaccine, Oral",
"url": "https://questionsmedicales.fr/mesh/D011055",
"about": {
"@type": "MedicalCondition",
"name": "Vaccin antipoliomyélitique oral",
"code": {
"@type": "MedicalCode",
"code": "D011055",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D20.215.894.899.623.750"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Vaccins contre la maladie d'Aujeszky",
"alternateName": "Pseudorabies Vaccines",
"url": "https://questionsmedicales.fr/mesh/D022421",
"about": {
"@type": "MedicalCondition",
"name": "Vaccins contre la maladie d'Aujeszky",
"code": {
"@type": "MedicalCode",
"code": "D022421",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D20.215.894.899.632"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Vaccins antirabiques",
"alternateName": "Rabies Vaccines",
"url": "https://questionsmedicales.fr/mesh/D011819",
"about": {
"@type": "MedicalCondition",
"name": "Vaccins antirabiques",
"code": {
"@type": "MedicalCode",
"code": "D011819",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D20.215.894.899.700"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Vaccins contre les virus respiratoires syncytiaux",
"alternateName": "Respiratory Syncytial Virus Vaccines",
"url": "https://questionsmedicales.fr/mesh/D022261",
"about": {
"@type": "MedicalCondition",
"name": "Vaccins contre les virus respiratoires syncytiaux",
"code": {
"@type": "MedicalCode",
"code": "D022261",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D20.215.894.899.730"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Vaccins anti-rotavirus",
"alternateName": "Rotavirus Vaccines",
"url": "https://questionsmedicales.fr/mesh/D022243",
"about": {
"@type": "MedicalCondition",
"name": "Vaccins anti-rotavirus",
"code": {
"@type": "MedicalCode",
"code": "D022243",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D20.215.894.899.760"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Vaccin antirubéoleux",
"alternateName": "Rubella Vaccine",
"url": "https://questionsmedicales.fr/mesh/D012411",
"about": {
"@type": "MedicalCondition",
"name": "Vaccin antirubéoleux",
"code": {
"@type": "MedicalCode",
"code": "D012411",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D20.215.894.899.779"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Vaccin contre la rougeole, les oreillons et la rubéole",
"alternateName": "Measles-Mumps-Rubella Vaccine",
"url": "https://questionsmedicales.fr/mesh/D022542",
"about": {
"@type": "MedicalCondition",
"name": "Vaccin contre la rougeole, les oreillons et la rubéole",
"code": {
"@type": "MedicalCode",
"code": "D022542",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D20.215.894.899.779.500"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Vaccins contre le SIDA simien",
"alternateName": "SAIDS Vaccines",
"url": "https://questionsmedicales.fr/mesh/D018449",
"about": {
"@type": "MedicalCondition",
"name": "Vaccins contre le SIDA simien",
"code": {
"@type": "MedicalCode",
"code": "D018449",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D20.215.894.899.790"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Vaccin antivariolique",
"alternateName": "Smallpox Vaccine",
"url": "https://questionsmedicales.fr/mesh/D012900",
"about": {
"@type": "MedicalCondition",
"name": "Vaccin antivariolique",
"code": {
"@type": "MedicalCode",
"code": "D012900",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D20.215.894.899.859"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Vaccins contre les hépatites virales",
"alternateName": "Viral Hepatitis Vaccines",
"url": "https://questionsmedicales.fr/mesh/D014761",
"about": {
"@type": "MedicalCondition",
"name": "Vaccins contre les hépatites virales",
"code": {
"@type": "MedicalCode",
"code": "D014761",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D20.215.894.899.955"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Vaccins anti-hépatite A",
"alternateName": "Hepatitis A Vaccines",
"url": "https://questionsmedicales.fr/mesh/D022362",
"about": {
"@type": "MedicalCondition",
"name": "Vaccins anti-hépatite A",
"code": {
"@type": "MedicalCode",
"code": "D022362",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D20.215.894.899.955.395"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Vaccins anti-hépatite B",
"alternateName": "Hepatitis B Vaccines",
"url": "https://questionsmedicales.fr/mesh/D017325",
"about": {
"@type": "MedicalCondition",
"name": "Vaccins anti-hépatite B",
"code": {
"@type": "MedicalCode",
"code": "D017325",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D20.215.894.899.955.400"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Vaccins contre le virus du Nil occidental",
"alternateName": "West Nile Virus Vaccines",
"url": "https://questionsmedicales.fr/mesh/D053060",
"about": {
"@type": "MedicalCondition",
"name": "Vaccins contre le virus du Nil occidental",
"code": {
"@type": "MedicalCode",
"code": "D053060",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D20.215.894.899.962"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Vaccin antiamaril",
"alternateName": "Yellow Fever Vaccine",
"url": "https://questionsmedicales.fr/mesh/D022341",
"about": {
"@type": "MedicalCondition",
"name": "Vaccin antiamaril",
"code": {
"@type": "MedicalCode",
"code": "D022341",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D20.215.894.899.970"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Vaccins antiviraux",
"alternateName": "Viral Vaccines",
"code": {
"@type": "MedicalCode",
"code": "D014765",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Yukai Huang",
"url": "https://questionsmedicales.fr/author/Yukai%20Huang",
"affiliation": {
"@type": "Organization",
"name": "Department of Microbiology, School of Basic Medicine, Zunyi Medical University, Zunyi, Guizhou, China."
}
},
{
"@type": "Person",
"name": "Xiao Guo",
"url": "https://questionsmedicales.fr/author/Xiao%20Guo",
"affiliation": {
"@type": "Organization",
"name": "Department of Microbiology, School of Basic Medicine, Zunyi Medical University, Zunyi, Guizhou, China."
}
},
{
"@type": "Person",
"name": "Yuancheng Zhou",
"url": "https://questionsmedicales.fr/author/Yuancheng%20Zhou",
"affiliation": {
"@type": "Organization",
"name": "Livestock and Poultry Biological Products Key Laboratory of Sichuan Province, Sichuan Animal Science Academy, Chengdu, China."
}
},
{
"@type": "Person",
"name": "Dongying Liu",
"url": "https://questionsmedicales.fr/author/Dongying%20Liu",
"affiliation": {
"@type": "Organization",
"name": "Department of Microbiology, School of Basic Medicine, Zunyi Medical University, Zunyi, Guizhou, China."
}
},
{
"@type": "Person",
"name": "Jingrui Mao",
"url": "https://questionsmedicales.fr/author/Jingrui%20Mao",
"affiliation": {
"@type": "Organization",
"name": "Department of Microbiology, School of Basic Medicine, Zunyi Medical University, Zunyi, Guizhou, China."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Cisplatin Binding to Human Serum Transferrin: A Crystallographic Study.",
"datePublished": "2023-01-05",
"url": "https://questionsmedicales.fr/article/36602395",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1021/acs.inorgchem.2c04206"
}
},
{
"@type": "ScholarlyArticle",
"name": "Cisplatin Nephrotoxicity: Novel Insights Into Mechanisms and Preventative Strategies.",
"datePublished": "2023-05-12",
"url": "https://questionsmedicales.fr/article/37182407",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.semnephrol.2023.151341"
}
},
{
"@type": "ScholarlyArticle",
"name": "PINK1 regulates apoptosis of osteosarcoma as the target gene of cisplatin.",
"datePublished": "2023-02-23",
"url": "https://questionsmedicales.fr/article/36823640",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s13018-023-03615-w"
}
},
{
"@type": "ScholarlyArticle",
"name": "MicroRNAs as Predictors of Lung-Cancer Resistance and Sensitivity to Cisplatin.",
"datePublished": "2022-07-08",
"url": "https://questionsmedicales.fr/article/35886942",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3390/ijms23147594"
}
},
{
"@type": "ScholarlyArticle",
"name": "Hypoxia, but Not Normoxia, Reduces Effects of Resveratrol on Cisplatin Treatment in A2780 Ovarian Cancer Cells: A Challenge for Resveratrol Use in Anticancer Adjuvant Cisplatin Therapy.",
"datePublished": "2023-03-16",
"url": "https://questionsmedicales.fr/article/36982788",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3390/ijms24065715"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Mélanges complexes",
"item": "https://questionsmedicales.fr/mesh/D045424"
},
{
"@type": "ListItem",
"position": 3,
"name": "Produits biologiques",
"item": "https://questionsmedicales.fr/mesh/D001688"
},
{
"@type": "ListItem",
"position": 4,
"name": "Vaccins",
"item": "https://questionsmedicales.fr/mesh/D014612"
},
{
"@type": "ListItem",
"position": 5,
"name": "Vaccins antiviraux",
"item": "https://questionsmedicales.fr/mesh/D014765"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Vaccins antiviraux - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Vaccins antiviraux",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-16",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Vaccins antiviraux",
"description": "Comment diagnostiquer une infection virale ?\nQuels tests sont utilisés pour les vaccins antiviraux ?\nLes symptômes indiquent-ils un besoin de vaccin ?\nComment évaluer l'efficacité d'un vaccin ?\nLes tests de dépistage sont-ils nécessaires avant vaccination ?",
"url": "https://questionsmedicales.fr/mesh/D014765?mesh_terms=Cisplatin&page=3#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Vaccins antiviraux",
"description": "Quels symptômes nécessitent un vaccin antiviral ?\nLes effets secondaires des vaccins sont-ils fréquents ?\nComment distinguer une infection d'un effet secondaire ?\nLes symptômes varient-ils selon le type de vaccin ?\nLes symptômes d'une infection virale sont-ils similaires ?",
"url": "https://questionsmedicales.fr/mesh/D014765?mesh_terms=Cisplatin&page=3#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Vaccins antiviraux",
"description": "Comment les vaccins antiviraux préviennent-ils les infections ?\nÀ quel âge doit-on commencer la vaccination antivirale ?\nLes vaccins antiviraux sont-ils sûrs pour les femmes enceintes ?\nLes vaccins protègent-ils contre toutes les souches virales ?\nQuelle est l'importance de la vaccination de masse ?",
"url": "https://questionsmedicales.fr/mesh/D014765?mesh_terms=Cisplatin&page=3#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Vaccins antiviraux",
"description": "Les vaccins antiviraux sont-ils des traitements ?\nQuels traitements sont disponibles après infection ?\nLes vaccins peuvent-ils réduire la gravité des symptômes ?\nLes traitements sont-ils nécessaires après vaccination ?\nLes vaccins antiviraux nécessitent-ils des traitements préventifs ?",
"url": "https://questionsmedicales.fr/mesh/D014765?mesh_terms=Cisplatin&page=3#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Vaccins antiviraux",
"description": "Quelles complications peuvent survenir après vaccination ?\nLes complications sont-elles fréquentes ?\nComment gérer les complications post-vaccinales ?\nLes complications varient-elles selon le vaccin ?\nLes complications peuvent-elles affecter l'immunité ?",
"url": "https://questionsmedicales.fr/mesh/D014765?mesh_terms=Cisplatin&page=3#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Vaccins antiviraux",
"description": "Quels sont les facteurs de risque pour les infections virales ?\nLes antécédents médicaux influencent-ils la vaccination ?\nLes voyages augmentent-ils le risque d'infection ?\nLes personnes âgées ont-elles plus de risques ?\nLe mode de vie influence-t-il le risque d'infection ?",
"url": "https://questionsmedicales.fr/mesh/D014765?mesh_terms=Cisplatin&page=3#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une infection virale ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur des tests virologiques, des analyses sanguines et des symptômes cliniques."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour les vaccins antiviraux ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests sérologiques et des cultures virales sont souvent utilisés pour évaluer l'immunité."
}
},
{
"@type": "Question",
"name": "Les symptômes indiquent-ils un besoin de vaccin ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des symptômes comme la fièvre ou la fatigue peuvent indiquer une infection nécessitant un vaccin."
}
},
{
"@type": "Question",
"name": "Comment évaluer l'efficacité d'un vaccin ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'efficacité est évaluée par des études cliniques et des taux d'infection dans la population vaccinée."
}
},
{
"@type": "Question",
"name": "Les tests de dépistage sont-ils nécessaires avant vaccination ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests peuvent être recommandés pour certaines populations à risque avant la vaccination."
}
},
{
"@type": "Question",
"name": "Quels symptômes nécessitent un vaccin antiviral ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des symptômes comme la toux, la fièvre ou des douleurs musculaires peuvent indiquer un besoin."
}
},
{
"@type": "Question",
"name": "Les effets secondaires des vaccins sont-ils fréquents ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les effets secondaires comme la douleur au site d'injection sont courants mais généralement légers."
}
},
{
"@type": "Question",
"name": "Comment distinguer une infection d'un effet secondaire ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les infections présentent des symptômes persistants, tandis que les effets secondaires sont temporaires."
}
},
{
"@type": "Question",
"name": "Les symptômes varient-ils selon le type de vaccin ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les symptômes peuvent varier selon le type de vaccin et la réponse immunitaire individuelle."
}
},
{
"@type": "Question",
"name": "Les symptômes d'une infection virale sont-ils similaires ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, de nombreuses infections virales partagent des symptômes comme la fièvre et la fatigue."
}
},
{
"@type": "Question",
"name": "Comment les vaccins antiviraux préviennent-ils les infections ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils stimulent le système immunitaire à reconnaître et combattre les virus spécifiques."
}
},
{
"@type": "Question",
"name": "À quel âge doit-on commencer la vaccination antivirale ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'âge de vaccination dépend du vaccin, mais beaucoup commencent dès l'enfance."
}
},
{
"@type": "Question",
"name": "Les vaccins antiviraux sont-ils sûrs pour les femmes enceintes ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certains vaccins sont sûrs pendant la grossesse, mais il est essentiel de consulter un médecin."
}
},
{
"@type": "Question",
"name": "Les vaccins protègent-ils contre toutes les souches virales ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, les vaccins ciblent des souches spécifiques, et des mises à jour peuvent être nécessaires."
}
},
{
"@type": "Question",
"name": "Quelle est l'importance de la vaccination de masse ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "La vaccination de masse aide à atteindre l'immunité collective et à réduire la propagation des virus."
}
},
{
"@type": "Question",
"name": "Les vaccins antiviraux sont-ils des traitements ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, les vaccins préviennent les infections, tandis que les traitements ciblent les infections existantes."
}
},
{
"@type": "Question",
"name": "Quels traitements sont disponibles après infection ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des antiviraux comme l'oseltamivir peuvent être prescrits pour traiter certaines infections virales."
}
},
{
"@type": "Question",
"name": "Les vaccins peuvent-ils réduire la gravité des symptômes ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les vaccins peuvent atténuer la gravité des symptômes en cas d'infection post-vaccination."
}
},
{
"@type": "Question",
"name": "Les traitements sont-ils nécessaires après vaccination ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Pas nécessairement, mais des traitements peuvent être requis si une infection survient malgré la vaccination."
}
},
{
"@type": "Question",
"name": "Les vaccins antiviraux nécessitent-ils des traitements préventifs ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, les vaccins sont une mesure préventive, mais des traitements peuvent être nécessaires en cas d'exposition."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir après vaccination ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications rares incluent des réactions allergiques sévères ou des syndromes neurologiques."
}
},
{
"@type": "Question",
"name": "Les complications sont-elles fréquentes ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, la plupart des complications sont rares et les bénéfices de la vaccination l'emportent sur les risques."
}
},
{
"@type": "Question",
"name": "Comment gérer les complications post-vaccinales ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Consulter un professionnel de santé pour évaluer et traiter les complications éventuelles."
}
},
{
"@type": "Question",
"name": "Les complications varient-elles selon le vaccin ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, chaque vaccin peut avoir des profils de complications différents selon sa composition."
}
},
{
"@type": "Question",
"name": "Les complications peuvent-elles affecter l'immunité ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines complications peuvent temporairement affecter la réponse immunitaire, mais cela est rare."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque pour les infections virales ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent l'âge, les maladies chroniques, et l'immunodépression."
}
},
{
"@type": "Question",
"name": "Les antécédents médicaux influencent-ils la vaccination ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des antécédents de réactions allergiques ou de maladies peuvent influencer le choix du vaccin."
}
},
{
"@type": "Question",
"name": "Les voyages augmentent-ils le risque d'infection ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, voyager dans des zones à risque peut augmenter l'exposition à des virus spécifiques."
}
},
{
"@type": "Question",
"name": "Les personnes âgées ont-elles plus de risques ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les personnes âgées sont plus susceptibles de développer des complications graves liées aux infections."
}
},
{
"@type": "Question",
"name": "Le mode de vie influence-t-il le risque d'infection ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un mode de vie sain, incluant une bonne nutrition et de l'exercice, peut réduire le risque."
}
}
]
}
]
}
The molecular mechanism of how human serum transferrin (hTF) recognizes cisplatin at the atomic level is still unclear. Here, we report the molecular structure of the adduct formed upon the reaction o...
Cisplatin is a highly effective chemotherapeutic agent that has been used for more than 50 years for a variety of cancers; however, its use is limited by toxicity, including nephrotoxicity. In this in...
Osteosarcoma is a common primary bone malignancy prevalent among adolescents and young adults. PTEN-induced kinase 1 (PINK1) regulates Parkinson's disease, but its role in cancers is unknown....
This study was designed to analyze the mechanism by which PINK1 affects osteosarcoma using bioinformatics and cell experiments....
The gene expression profiles were downloaded from the TARGET database. Several online databases were used to analyze the expression and protein‒protein interaction networks. CCK-8 cell viability assay...
Through bioinformatics analysis, we found that high expression of PINK1 was associated with poor prognosis in patients with osteosarcoma, and PINK1 inhibited apoptosis and promoted proliferation pathw...
Collectively, our findings demonstrate that PINK1 is crucially involved in osteosarcoma and suggests that it can promote the apoptosis of OS cells as the downstream target gene of cisplatin....
Platinum-based chemotherapy, cisplatin (DDP) specifically, is the main strategy for treating lung cancer (LC). However, currently, there is a lack of predictive drug-resistance markers, and there is i...
Data on miRNAs associated with LC DDP chemotherapy response are summarized and analyzed....
A comprehensive review of the data in the literature and an analysis of bioinformatics resources were performed. The gene targets of miRNAs, as well as their reciprocal relationships with miRNAs, were...
The complex analysis of bioinformatics resources and the literature indicated that the expressions of 12 miRNAs have a high predictive potential for LC DDP chemotherapy responses. The obtained informa...
An overview of the published data and bioinformatics resources, with respect to the predictive microRNA markers of chemotherapy response, is presented in this review. The selected microRNAs and gene p...
Natural compounds, such as resveratrol (Res), are currently used as adjuvants for anticancer therapies. To evaluate the effectiveness of Res for the treatment of ovarian cancer (OC), we screened the r...
Gemcitabine/cisplatin (GC) combination therapy has been the standard palliative chemotherapy for patients with advanced biliary tract cancer (BTC). No randomized clinical trials have been able to demo...
We performed a mulitcenter, randomized phase III trial across 39 centers. Enrolled patients were randomly allocated (1:1) to either the GCS or GC arm. The GCS regimen comprised gemcitabine (1000 mg/m...
Between July 2014 and February 2016, 246 patients were enrolled. The median OS and 1-year OS rate were 13.5 months and 59.4% in the GCS arm and 12.6 months and 53.7% in the GC arm, respectively (hazar...
GCS is the first regimen which demonstrated survival benefits as well as higher RR over GC in a randomized phase III trial and could be the new first-line standard chemotherapy for advanced BTC. To ex...
Cisplatin is an antineoplastic medicine used in the treatment for various types of cancer. Among its side effects is ototoxicity, which may result in a bilateral and irreversible hearing loss. The oto...
Cisplatin-based chemotherapy has been widely used in the treatment of lung adenocarcinoma (LUAD). However, the development of cisplatin resistance becomes a major obstacle impeding the curative effect...
Based on the CCLE database, lung cancer cell lines were divided into cisplatin-resistant and cisplatin-sensitive groups. The differentially expressed miRNAs were filtered and further identified by sur...
In this study, miR-375 showed the ability to promote cisplatin sensitivity and apoptosis of LUAD. Genes correlated with miR-375 in LUAD were analyzed and ABCC8 showed the strongest positive correlatio...
Overall, this study provides new insights into the role of miR-375 in the cisplatin sensitivity of LUAD. Our present findings may serve as a theoretical basis for new therapeutic strategies and predic...
With the scarcity of pharmacological otoprotective agents against cisplatin-induced ototoxicity (CIO), researchers find themselves compelled to look at and navigate all possible strategies to identify...
Osteosarcomas are prevalent in children and young adults and have a high recurrence rate. Cisplatin, doxorubicin, and methotrexate are common adjuvant chemotherapy drugs for treatment of osteosarcoma,...